Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.03 – $0.11
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $3.6K | $8.3K | $8.0K | $11.5K |
| Gross profit | $0 | $0 | $0 | $0 | −$3.6K | −$8.3K | −$8.0K | −$11.5K |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $0 | $0 | $544.5K | $2.0M | $977.8K | $1.1M | $112.3K | $454.0K |
| Operating income | −$214.7K | −$1.6M | −$1.3M | −$4.2M | −$2.1M | −$3.8M | −$2.2M | −$1.9M |
| EBITDA | $0 | $0 | $0 | −$4.2M | −$2.1M | −$3.8M | −$2.2M | −$1.8M |
| Net income | −$296.4K | −$2.1M | −$3.8M | −$4.3M | −$2.5M | −$4.3M | −$2.4M | −$2.1M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -0.00 | -0.02 | -0.04 | -0.04 | -0.02 | -0.03 | -0.02 | -0.02 |
Annual figures · source: Financial Modeling Prep
BIOXYTRAN INC
No one on the platform currently holds BIXT.
No tracked institution reports a position in BIXT as of their last filing.
No one on the platform has traded BIXT yet.
| $5M |
| — |
| GLWLFGlow Lifetech Corp. | $0.03 | +0.00% | $6M | — |
| KNBIFKane Biotech Inc. | $0.02 | +0.00% | $4M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$BIXT as of 3:35p ET on Wed, June 17, 2026....not a single share traded yet today according to Etrade...wow
View on StockTwits ↗$BIXT I'm surprise this company hasn't provided any news. Firm believer in a spike coming soon.
View on StockTwits ↗$BIXT out for now. too many other stocks that are crushing it right now
View on StockTwits ↗$BIXT https://www.bioxytraninc.com/press-releases/bioxytran-announces-positive-dose-optimization-results-and-advances-toward-phase-3-registrational-trial-for-prolectin-m
View on StockTwits ↗$BIXT This one hasn't moved! Looking forward to some news on A-SUQAR and commercialization!!!
View on StockTwits ↗$BIXT 3:15p ET, still zero shares traded so far today...??
View on StockTwits ↗$BIXT 3hrs into a Monday trading day and zero shares traded so far...
View on StockTwits ↗$BIXT I still like this company even though the stock price hasn't move at all. When is A-SUQAR launching?
View on StockTwits ↗$ICU $CGTX $PSRHF $BIXT $VPLM LOL these are my big winners today!! keeping me green!! never would I have guessed a day would have this combo as big gainers for me. GLTALs!!
View on StockTwits ↗$BIXT whoever the private placement party was, they paid 5.5 cents per share, and received warrants exerciseable at 12 cents per share. I'm liking my cost basis...GLTALs!!
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.